Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast CancerJosé Baselga, Frederico Costa, Brigitte Van Eyll et al.|Journal of Clinical Oncology|2012Cited by 163